Follow the Drugs Made In America Acquisition Corp. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.1bn. The latest transaction was disclosed on 18 February 2025 (Acquisition). Among the most active insiders: Stockwell Lynn. All data is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 7,123 of 29,055 companies
64.3
score / 100
Value
71
Quality
58
FCF yld14%
Earn yld0.5%
EV/EBITDA5.0x
ROE12%
Gross mgn58%
Net mgn0.5%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Drugs Made In America Acquisition Corp. is a special purpose acquisition company focused on the pharmaceutical sector. It aims to identify and acquire innovative companies within this field.